Cargando…

Mass drug administration for malaria

Mostrar otras versiones (1)

BACKGROUND: Mass drug administration (MDA), defined as the empiric administration of a therapeutic antimalarial regimen to an entire population at the same time, has been a historic component of many malaria control and elimination programmes, but is not currently recommended. With renewed interest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poirot, Eugenie, Skarbinski, Jacek, Sinclair, David, Kachur, S Patrick, Slutsker, Laurence, Hwang, Jimee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2013
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468927/ https://www.ncbi.nlm.nih.gov/pubmed/24318836 http://dx.doi.org/10.1002/14651858.CD008846.pub2

Ejemplares similares

Review of Mass Drug Administration for Malaria and Its Operational Challenges
por: Newby, Gretchen, et al.
Publicado: (2015)

Mass drug administration for malaria
por: Shah, Monica P, et al.
Publicado: (2021)

It is time to rethink tactics in the fight against malaria
por: Slutsker, Laurence, et al.
Publicado: (2013)

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China
por: Hsiang, Michelle S, et al.
Publicado: (2013)

Knowledge of Malaria and Its Association with Malaria-Related Behaviors—Results from the Malaria Indicator Survey, Ethiopia, 2007
por: Hwang, Jimee, et al.
Publicado: (2010)

Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests
por: Masanja, Irene M, et al.
Publicado: (2012)

Moving from Malaria Burden Reduction toward Elimination: An Evaluation of Mass Drug Administration in Southern Province, Zambia
por: Miller, John M., et al.
Publicado: (2020)

Severe Morbidity and Mortality Risk From Malaria in the United States, 1985–2011
por: Hwang, Jimee, et al.
Publicado: (2014)

Caution is required when using health facility-based data to evaluate the health impact of malaria control efforts in Africa
por: Rowe, Alexander K, et al.
Publicado: (2009)

Correct dosing of artemether-lumefantrine for management of uncomplicated malaria in rural Tanzania: do facility and patient characteristics matter?
por: Masanja, Irene M, et al.
Publicado: (2013)

A Longitudinal Cohort to Monitor Malaria Infection Incidence during Mass Drug Administration in Southern Province, Zambia
por: Bennett, Adam, et al.
Publicado: (2020)

Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
por: Gutman, Julie, et al.
Publicado: (2012)

A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
por: Agarwal, Aarti, et al.
Publicado: (2013)

Defining operational research priorities to improve malaria control and elimination in sub-Saharan Africa: results from a country-driven research prioritization setting process
por: Tine, Roger, et al.
Publicado: (2023)

Multidrug-resistant malaria and the impact of mass drug administration
por: Zuber, Janie Anne, et al.
Publicado: (2018)

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
por: Chen, Ingrid, et al.
Publicado: (2015)

Using Respondent Driven Sampling to Identify Malaria Risks and Occupational Networks among Migrant Workers in Ranong, Thailand
por: Wangroongsarb, Piyaporn, et al.
Publicado: (2016)

A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting—high coverage and safety, but no significant impact on transmission
por: Morris, Ulrika, et al.
Publicado: (2018)

How Patients Take Malaria Treatment: A Systematic Review of the Literature on Adherence to Antimalarial Drugs
por: Bruxvoort, Katia, et al.
Publicado: (2014)

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned
por: Odero, Norbert Awino, et al.
Publicado: (2019)

Estimating the Burden of Malaria: The Need for Improved Surveillance
por: Mueller, Ivo, et al.
Publicado: (2011)

Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial
por: Abdelmenan, Semira, et al.
Publicado: (2022)

Mass Drug Administration of Artemisinin-piperaquine on High Malaria Epidemic Area
por: Deng, Changsheng, et al.
Publicado: (2014)

A stochastic model for the probability of malaria extinction by mass drug administration
por: Pemberton-Ross, Peter, et al.
Publicado: (2017)

Malaria Elimination in Costa Rica: Changes in Treatment and Mass Drug Administration
por: Chaves, Luis F., et al.
Publicado: (2020)

Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar
por: Kyaw, Shwe Sin, et al.
Publicado: (2021)

Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration
por: Anwar, Md Nurul, et al.
Publicado: (2023)

Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trial
por: Samuels, Aaron M., et al.
Publicado: (2017)

Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone
por: Aregawi, Maru, et al.
Publicado: (2016)

Mass drug administration can be a valuable addition to the malaria elimination toolbox
por: Eisele, Thomas P.
Publicado: (2019)

In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia
por: Hwang, Jimee, et al.
Publicado: (2011)

Opportunities for Subnational Malaria Elimination in High-Burden Countries
por: Lindblade, Kim A., et al.
Publicado: (2020)

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
por: Haston, Julia C., et al.
Publicado: (2019)

‘Beyond “test and treat” – malaria diagnosis for improved pediatric fever management in sub-Saharan Africa’ by Emily White Johansson
por: Kachur, S. Patrick
Publicado: (2016)

Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin–Piperaquine Implemented in Southern Province, Zambia
por: Eisele, Thomas P., et al.
Publicado: (2020)

The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study
por: Peto, Thomas J, et al.
Publicado: (2018)

Mass drug administration for malaria elimination: do we understand the settings well enough?
por: Hetzel, Manuel W., et al.
Publicado: (2018)

Malaria resurgence after significant reduction by mass drug administration on Ngodhe Island, Kenya
por: Kagaya, Wataru, et al.
Publicado: (2019)

Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration
por: Wu, Lindsey, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bqvtlq7v7627hpg4q23vqsvurc